Back to Search Start Over

Colonic stenting as a bridge to surgery versus emergency surgery for malignant colonic obstruction: results of a multicentre randomised controlled trial (ESCO trial).

Authors :
Arezzo, Alberto
Bannone, Elisa
Forcignanò, Edoardo
Bonino, Marco
Morino, Mario
Balague, Carmen
Targarona, Eduardo
Borghi, Felice
Giraudo, Giorgio
Ghezzo, Luigi
Arroyo, Antonio
Sola-Vera, Javier
De Paolis, Paolo
Bossotti, Maurizio
Passera, Roberto
Forcignanò, Edoardo
Bonino, Marco Augusto
Source :
Surgical Endoscopy & Other Interventional Techniques. Aug2017, Vol. 31 Issue 8, p3297-3305. 9p. 7 Charts, 2 Graphs.
Publication Year :
2017

Abstract

<bold>Background: </bold>The aim of colonic stenting with self-expandable metallic stents in neoplastic colon obstruction is to avoid emergency surgery and thus potentially reduce morbidity, mortality, and need for a stoma. Concern has been raised, however, about the effect of colonic stenting on short-term complications and long-term survival. We compared morbidity rates after colonic stenting as a bridge to surgery (SBTS) versus emergency surgery (ES) in the management of left-sided malignant large-bowel obstruction.<bold>Methods: </bold>This multicentre randomised controlled trial was designed with the endorsement of the European Association for Endoscopic Surgery. The study population was consecutive patients with acute, symptomatic malignant left-sided large-bowel obstruction localised between the splenic flexure and 15 cm from the anal margin. The primary outcome was overall morbidity within 60 days after surgery.<bold>Results: </bold>Between March 2008 and November 2015, 144 patients were randomly assigned to undergo either SBTS or ES; 29/144 (13.9%) were excluded post-randomisation mainly because of wrong diagnosis at computed tomography examination. The remaining 115 patients (SBTS n = 56, ES n = 59) were deemed eligible for analysis. The complications rate within 60 days was 51.8% in the SBTS group and 57.6% in the ES group (p = 0.529). Although long-term follow-up is still ongoing, no statistically significant difference in 3-year overall survival (p = 0.998) and progression-free survival rates between the groups has been observed (p = 0.893). Eleven patients in the SBTS group and 23 in the ES group received a stoma (p = 0.031), with a reversal rate of 30% so far.<bold>Conclusions: </bold>Our findings indicate that the two treatment strategies are equivalent. No difference in oncologic outcome was found at a median follow-up of 36 months. The significantly lower stoma rate noted in the SBTS group argues in favour of the SBTS procedure when performed in expert hands. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
18666817
Volume :
31
Issue :
8
Database :
Academic Search Index
Journal :
Surgical Endoscopy & Other Interventional Techniques
Publication Type :
Academic Journal
Accession number :
123992617
Full Text :
https://doi.org/10.1007/s00464-016-5362-3